and of course ... there is this ...
5:55pm, Panel Presentation - Innovation in Immunotherapy & Vaccines
- Rahul Jasuja, Ph.D., Managing Director, Biotechnology Research, Noble Financial Capital Markets - Moderator
- Dr. Phil Greenberg, Head of the Program in Immunology at the Fred Hutchinson Cancer Research Center- KOL
Inovio: Joseph Kim, Ph.D., CEO
Galena: Mark Ahn, Ph.D., CEO
Argos: Charles Nicolette, Ph.D., Chief Scientific Officer
•••••• Prima Biomed: Neil Frazer, M.D., Chief Medical Officer
Newlink Genetics: Charles Link, M.D., Chief Medical Officer
strong support, page-35
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.010(3.08%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.0¢ | $584.2K | 1.787M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 311433 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 113721 | 6 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |